Select area to zoom
Created with Highcharts 11.1.0Jul '24Oct '24Jan '25Apr '25100.0056.89

Key Stats

Customize
Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.93% -0.17% 608.31M 2.258M
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.22% 179.0% -245.55M Upgrade

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Equity
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

There are no valid items on this chart.

Name
2018
2019
2020
2021
2022
2023
2024
YTD
-57.60%
75.51%
74.66%
-64.15%
-80.36%
-13.42%
-26.02%
-36.70%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
1.56%
-56.75%
70.73%
-76.58%
108.3%
-54.10%
-55.81%
15.53%
-31.11%
-14.62%
63.45%
21.53%
60.57%
-38.98%
46.66%
43.47%
-2.46%
-25.11%
82.02%
-55.64%
153.4%
-67.24%
12.06%
-5.26%
-1.10%
-49.88%
43.94%
6.13%
-20.81%
-60.25%
7.43%
-2.05%
24.21%
As of June 06, 2025.

Asset Allocation

Created with Highcharts 11.1.0
As of April 30, 2025.
Type % Net
Cash 5.43%
Stock 63.99%
Bond 38.34%
Convertible 0.00%
Preferred 0.00%
Other -7.76%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Equity
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders

Quickflows